SCHEMBL18006245

SCHEMBL18006245

Cc1nc(-c2cccc(COc3cc(-c4nn[nH]c4C#N)cc(C(F)(F)F)c3)c2)cs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.42
PRKDC P78527 1/20 0.39
SCN9A Q15858 1/20 0.36
ALOX5 P09917 1/20 0.35
PSEN1 P49768 1/20 0.35
F2RL3 Q96RI0 1/20 0.34
TSHR P16473 1/20 0.34
RECQL P46063 1/20 0.34
LMNA P02545 2/20 0.33
FFAR1 O14842 2/20 0.33
MRGPRX4 Q96LA9 1/20 0.33
CTSS P25774 3/20 0.33
CTSK P43235 2/20 0.33
HTT P42858 1/20 0.33
GAA P10253 1/20 0.33
EGFR P00533 1/20 0.33
ERBB2 P04626 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18006216 0.84 FFAR1 (0.41) PRMT6LMNAFFAR1MRGPRX4
SCHEMBL18006178 0.83 CTSS (0.33) CTSSCTSKMAPT
SCHEMBL18006218 0.83 MPO (0.40) FFAR1MRGPRX4CTSK
SCHEMBL18004316 0.83 MAOB (0.46) FFAR1MRGPRX4HTTMAPT
SCHEMBL18006242 0.83 POLB (0.39) PRMT6LMNAFFAR1MRGPRX4
SCHEMBL16398800 0.83 MRGPRX4 (0.39) FFAR1MRGPRX4
SCHEMBL18006219 0.83 MRGPRX4 (0.37) FFAR1MRGPRX4
SCHEMBL18006220 0.82 FFAR1 (0.43) FFAR1MRGPRX4
SCHEMBL18004313 0.81 MAOB (0.39) PSEN1MRGPRX4CTSSMEN1KMT2A
SCHEMBL18006174 0.80 USP7 (0.39) MRGPRX4CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 EP disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626095-B2 Cyanotriazole compounds CS, PC, ACAT1 PRMT6 1419/4885PRKDC 2419/4885SCN9A 3205/4885
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS CS, PC, ACAT1 PRMT6 1419/4885PRKDC 2419/4885SCN9A 3205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.